Raman signals of pre-blocked groups decreased by about 30% compared with the unblocked group, indicating that the nanomaterial is sensitive and specific to distinguish breast cancer with different expression levels of PDL1 and EGFR. This evidence concerns the gene CD274 and breast carcinoma.